| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 8985 | WLN: 1R D-I-R D1 &E &6/14 | 0.049093561024907 | 0.26291683 |
| NSC 405029 | Null | 1.92684808686041e-005 | 0.42401342 |
| NSC 727087 | 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate | 1.92684808686041e-005 | 0.32925424 |
| NSC 671170 | Null | 3.40252996142932e-005 | 0.60367376 |
| NSC 619859 | 1H-3-Benzazepin-2-one, 2,3,4,5-tetrahydro-7,8-dimethoxy- 3-[(2,3-dimethoxyphenyl)methyl]-1-methylthio- | 3.84182410752305e-006 | 0.67615382 |
| NSC 650772 | 4-Methylthio-N-(3,4,5-trimethoxybenzyl)aniline Hydrochloride | 4.23926332038871e-006 | 0.68038279 |
| NSC 107043 | Null | 4.91939766674006e-005 | 0.51025387 |
| NSC 48526 | Null | 4.91939766674006e-005 | 0.14217434 |
| NSC 79563 | 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine | 5.49145982993956e-005 | 0.40470562 |
| NSC 641233 | 2-Naphthalenebutanamide, N-(3-chloro-1,4-dihydro- 1,4-dioxo-2-naphthalenyl)-.beta.-(1,3-dihydro-3-oxo- 1-isoindolyl)-.alpha.-,-.gamma.-dioxo- | 5.49145982993959e-005 | 0.39533763 |